10-Q
Quarterly Report
Autonomix Medical, Inc.
AMIX
NASDAQ
CIK: 1617867
File #: 001-41940
Balance Sheet
24 line items · 2 periods
XBRL
| Item | Dec 31, 2025 | Mar 31, 2025 |
|---|---|---|
Current assets: | ||
Cash and cash equivalents | 9,934,000 | 9,136,000 |
Other current assets | 257,000 | 473,000 |
Total current assets | 10,191,000 | 9,609,000 |
Noncurrent assets: | ||
Property and equipment, net | 20,000 | 21,000 |
Deferred offering costs | 0 | 176,000 |
Total noncurrent assets | 20,000 | 197,000 |
Total Assets | 10,211,000 | 9,806,000 |
Current liabilities: | ||
Accounts payable | 714,000 | 676,000 |
Accrued expenses | 936,000 | 1,031,000 |
Total current liabilities | 1,650,000 | 1,707,000 |
Total Liabilities | 1,650,000 | 1,707,000 |
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2025 and March 31, 2025, respectively | 0 | 0 |
Common stock, $0.001 par value, 500,000,000 shares authorized, 11,409,344 and 2,497,033 shares issued and outstanding as of December 31, 2025 and March 31, 2025, respectively | 11,000 | 2,000 |
Additional paid-in capital | 72,977,000 | 58,476,000 |
Accumulated deficit | (64,427,000) | (50,379,000) |
Total Stockholders' Equity | 8,561,000 | 8,099,000 |
Common Stock | 11,000 | 2,000 |
Additional Paid-in Capital | 72,977,000 | 58,476,000 |
Retained Earnings | (64,427,000) | (50,379,000) |
Total Liabilities and Stockholders' Equity | 10,211,000 | 9,806,000 |